The application of the phosphoramidate ProTide approach confers micromolar potency against Hepatitis C virus on inactive agent 4'-azidoinosine: Kinase bypass on a dual base/sugar modified nucleosideMCGUIGAN, Christopher; DAVERIO, Felice; NAJERA, Isabel et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 11, pp 3122-3124, issn 0960-894X, 3 p.Article

Enhanced inhibition of the EDHF phenomenon by a phenyl methoxyalaninyl phosphoramidate derivative of dideoxyadenosineGRIFFITH, Tudor M; CHAYTOR, Andrew T; EDWARDS, David H et al.British journal of pharmacology. 2004, Vol 142, Num 1, pp 27-30, issn 0007-1188, 4 p.Article

First example of phosphoramidate approach applied to a 4'-substituted purine nucleoside (4'-azidoadenosine) : Conversion of an inactive nucleoside to a submicromolar compound versus hepatitis C virusPERRONE, Plinio; DAVERIO, Felice; MCGUIGAN, Christopher et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 22, pp 5463-5470, issn 0022-2623, 8 p.Article

The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479)MCGUIGAN, Christopher; ROSE KELLEHER, Mary; KLUMPP, Klaus et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 15, pp 4250-4254, issn 0960-894X, 5 p.Article